VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ 18 years or older                                  │ 18 years or older                                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Chest radiograph showing new opacities             │ Chest radiograph showing new opacities             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cough                                              │ Cough                                              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Production of sputum                               │ Production of sputum                               │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Audible abnormalities by chest examination         │ Audible abnormalities by chest examination         │     100 │
│ compatible with pneumonia                          │ compatible with pneumonia                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Immunocompromised patients                         │ Immunocompromised patients                         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with a known congenital or acquired       │ Patients with a known congenital or acquired       │     100 │
│ immunodeficiency                                   │ immunodeficiency                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who received chemotherapy less than 6     │ Patients who received chemotherapy less than 6     │     100 │
│ weeks ago                                          │ weeks ago                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who received corticosteroids in the last  │ Patients who received corticosteroids in the last  │     100 │
│ 6 weeks                                            │ 6 weeks                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who received immunosuppressive medication │ Patients who received immunosuppressive medication │     100 │
│ in the last 6 weeks (e.g. cyclosporin,             │ in the last 6 weeks (e.g. cyclosporin,             │         │
│ cyclophosphamide, azathioprine)                    │ cyclophosphamide, azathioprine)                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with chronic obstructive pulmonary        │ Patients with chronic obstructive pulmonary        │     100 │
│ disease who are on systemic corticosteroids        │ disease who are on systemic corticosteroids        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients who require intensive care unit treatment │ Patients who require intensive care unit treatment │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with tropical worm infection              │ Patients with tropical worm infection              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with dexamethasone intolerance            │ Patients with dexamethasone intolerance            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant and breastfeeding women                   │ Pregnant and breastfeeding women                   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Temp \>38,0 °C or \<36,0 °C                        │ Temp >38,0 °C or <36,0 °C                          │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Leukocytosis (\>10.000 cells/mm3), leftward shift  │ Leukocytosis (>10.000 cells/mm3), leftward shift   │      98 │
│ (\>10%) or leucopenia (\<4000 cells/mm3)           │ (>10%) or leucopenia (<4000 cells/mm3)             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ C-reactive protein \> 15 mg/l (three fold higher   │ C-reactive protein > 15 mg/l (three fold higher    │      99 │
│ than the upper limit of normal)                    │ than the upper limit of normal)                    │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                          │   Score │
╞═══════════════════════════════════════════════════╪════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years                 │ Chest radiograph showing new opacities │      37 │
├───────────────────────────────────────────────────┼────────────────────────────────────────┼─────────┤
│ In combination with two of the following findings │ Patients with tropical worm infection  │      47 │
╘═══════════════════════════════════════════════════╧════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 93.85
OverAll Ratio: 94.425
